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Abstract 
Background: Maternal drug used during pregnancy may pose a teratogenic risk to the foetus and complications 
to the mother. However, the recommendation to avoid use of all drugs during pregnancy is unrealistic and may 
be dangerous, which depends on the risk benefit ratio to the mother and foetus. Proper use of medication during 
pregnancy is an essential part of prenatal care, since it can affect not only the health of the pregnant woman but 
also the developing foetus which is exposed to wide range of adverse effects.  
Design and Method: The study was retrospective descriptive cross sectional survey. The target population 
comprised of all the pregnant women attending ANC in Sir Yahaya Memorial Hospital Birnin Kebbi. Systematic 
sampling was used in selecting sample of the research. The sample size was calculated using the Cochran’s 
equation for sample proportion, at 95% confidence interval. Data was collected using structured questionnaire 
administered to the respondents during their clinic session. Face and content validity was used to validate the 
research instrument and test-retest reliability was used to ascertain the reliability of the questionnaire. Ethical 
approval was collected from Kebbi State Health Research Ethical Committee. Data was analysed using 
descriptive statistic in tables indicating percentages and frequencies; and Chi square statistical tool in hypotheses 
testing using SPSS version 20.  
Result: The result shows that 49.6% of the respondents were not taking the entire drugs prescribed to them. 
25.8% of the respondents believed that some drugs prescribed at ANC clinic may be detrimental to them or their 
foetuses. 20.7%, 21.3% and 20.0% of the respondents dislike multivamins, folic acid and fersolate respectively 
among the ANC prescribed drugs. 9.5% of the respondents think multivitamin is not important. 8.1%, 9.4% and 
6.1% of the respondents think fersolate, folic acid and calcium gluconate respectively are not important. The 
results show that at 0.05 level of significant age has no effect on the use of prescribed drugs, P >0.05; level of 
education has effect on common non-prescribed drugs pregnant women used, P <0.05. Number of deliveries has 
no effect on what the pregnant women do with the drugs they dislike, P >0.05. 
Conclusion: It is concluded that lack of knowledge, beliefs and wrong perception on the use of drugs have a 
tremendous influence on the way pregnant women use drugs. About half of the respondents take drugs for more 
than prescribed days which might leads to some teratogenic effects. It is recommended that more effort be 
applied in educating pregnant women on all aspect of drugs use in pregnancy especially during ANC visit. 
Importance of multivitamins, minerals and iron supplement in pregnancy should be stressed to the pregnant 
women attending ANC. 
Key words: Ante natal care, Assessment, Birnin-kebbi, Drugs use, Pregnant women, Nigeria  
1. Introduction 
Pregnancy is associated with profound physiological changes in woman's body. These unique changes challenge 
clinicians managing disease states during pregnancy in the selection of medications best suited to treat their 
patients. Maternal drug used during pregnancy may pose a teratogenic risk to the foetus and complications to the 
mother. However, the recommendation to avoid use of all drugs during pregnancy is unrealistic and may be 
dangerous, which depends on the risk benefit ratio to the mother and foetus1. Proper use of medication during 
pregnancy is an essential part of prenatal care, since it can affect not only the health of the pregnant woman but 
also the developing foetus which is exposed to wide range of adverse effects2, 3.  
In the developing world; poor health seeking behaviour of patients, delayed initiation of antenatal care (ANC), 
low level of educational status of mothers, lack of up to date information of health care providers, poor access to 
health facilities, and loose control over prescription and non-prescription drugs could aggravate irrational use of 
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drugs during pregnancy1. Some pregnant women are self medicating themselves with the use of over-the-counter 
drugs which can pose a lot of devastating effect to both the mother and developing foetus. Olesen, Sondergaard, 
& Thrane et al.4 stated that; non compliance for prescribed drugs during pregnancy is prevalent, but as the 
information for drug use might differ depending on how it was obtained, knowledge about drug used during 
pregnancy is still relatively unknown. According to Eze, Eferakeya, Oparah et al.5, information on the use of 
drugs during pregnancy is scarce and anecdotal. Despite the absence of adequate studies on safety and efficacy 
of drugs for pregnant women, evidence available shows that clinicians prescribe, and pregnant women take a 
surprisingly large number of drugs. An international investigation sponsored by World Health Organization 
(WHO) showed that pregnant women ingest an average of three prescription medications during pregnancy. 
Furthermore, 86% of the women had taken at least one prescription medication during their pregnancies5.  
The need for micronutrient supplementation in pregnancy in developing countries is likely to be great because of 
widespread maternal malnutrition. Public health resources, however, are limited and it is inevitable that priority 
will be given to interventions that are both efficacious and effective. Current evidence shows that some 
micronutrients, such as folate and iron and iodine in population-based iodine supplementation, can reduce the 
risk of adverse pregnancy outcomes. Others, such as calcium, vitamin A, and zinc, may reduce the incidence of 
ill health and some life-threatening complications of pregnancy that are still common in many developing 
countries6. Thus the use of such supplement cannot be ruled out from such countries. Currently, iron or iron and 
folate supplements are distributed to pregnant women in most developing countries free of charge or at low cost 
by public health authorities. Nevertheless, few data show that coverage is good or that anaemia prevalence rates 
are declining. 
Moreover, less-informed women may take more than the recommended dose on the premise that it is 
advantageous to the pregnancy outcome and the newborn infant's health. Toxic effects caused by overdosing are 
a major concern for anyone involved in prenatal care, especially for lipid-soluble vitamins such as A and D that 
have limited excretion routes. Also some pregnant women decline from taking the micronutrient supplement 
which may lead to having an underweight baby. Recent evidence suggests that infants who are small or 
disproportionate at birth have increased health risks later in life. The hypothesis is that such infants have had to 
adapt to a limited supply of nutrients and that in so doing their physiology and metabolism are permanently 
changed, although the rationale for this hypothesis has been challenged6. This research work will therefore assess 
drugs use among pregnant women attending ANC in Sir Yahaya Memorial Hospital Birnin Kebbi. 
2. Statement of the problem 
The provision of complete health care necessitates the availability of safe, effective and affordable drugs of the 
required quality, in adequate quantity all times. The irrational use of drugs has become a serious problem in 
developing countries. Consequences of inappropriate drug use includes increased morbidity and mortality, 
increased risk of unwanted effects, the emergence of drug resistance, waste of resource, and psychosocial effects. 
In the developing world; poor health seeking behaviour of patients, delayed initiation of ante natal care (ANC), 
low level of educational status of mothers, lack of up to date information of health care providers, poor access to 
health facilities, and loose control over prescription and non-prescription drugs could aggravate irrational use of 
drugs during pregnancy1. It is observed that some pregnant women decline from taking some micronutrient 
supplements which may leads to having underweight baby and consequent complications and suffering in labour. 
Pregnant women patronise over the counter drugs in the treatment of minor illnesses like vomiting, fever, lower 
abdominal pain and headache. The use of non-prescribed drugs by the pregnant women, and clinicians 
prescribing large number of drugs pose a great threat to the mother and foetus as some of the drugs may have 
some teratogenic effects. It therefore calls for special attention because in this case in addition to the mother, the 
health and life of her unborn child is also at stake. The drugs given to pregnant mothers for therapeutic purposes 
may cause serious structural and functional adverse effects in developing foetus. 
3. Significance of the study 
The research work will help in understanding the situation of drugs use in pregnancy in our society; it will serve 
as a pointer to whether the pregnant women and their foetuses are at risk of devastating effect of drugs over-
prescription, contra indicated drugs, over dosing and use of non-prescribed drugs or not. It serves as a preamble 
for overseen and tackling the problems associated with the drugs side effects and teratogenic effects in 
pregnancy in our hospitals. The research findings will also be helpful to the policy makers and hospitals 
management in formulating policies pertaining ante natal care and pregnancy management. Pregnant women will 
also benefit from the research as it provides a way by which they will be free from likely devastating effects of 
non-prescribed drugs, over prescription, over dosing and or contra indicated drugs. The benefits to the society 
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include the possibility of having fewer babies with congenital abnormalities that may not be productive to the 
societal development. 
4. General objective 
To assess drugs use among pregnant women attending ANC in Sir Yahaya Memorial Hospital Birnin Kebbi. 
Specific objectives 
1. To analyse the drugs used by pregnant women 
2. To determine if the pregnant women and their foetuses are at risk of drugs adverse effects 
3. To examine drugs compliance level of pregnant women 
5. Research questions 
1. Do the drugs used by the pregnant women harmful to them and their foetuses? 
2. Are the pregnant women and their foetuses at risk of drugs adverse effect? 
3. Do the pregnant women adhere with the micro nutrient supplement prescribed drugs? 
6. Research hypotheses 
The following were the null hypotheses of the research 
1. Age of the pregnant women has no effect on drugs use. 
2. Educational level of the pregnant women has no affect on drugs use. 
3. Number of deliveries has no effect on drugs use. 
7. Literature review 
7.1 Specific vitamin requirements 
As a component of prenatal care, micronutrient supplementation might reduce maternal morbidity and mortality 
directly by treating a pregnancy-related illness or indirectly by lowering the risk of complications at delivery. 
Nevertheless, the effectiveness of supplementation programs—notably of iron and folate—has tended to focus 
on infant outcomes, perinatal mortality, preterm delivery, and low birth weight6. 
Folic acid 
The naturally occurring, water-soluble vitamin folate is integral to the synthesis and maintenance of DNA, 
metabolism of amino acids, production of red blood cells, and growth of the fetus and placenta7. Folic acid is a 
synthetic compound that is used as a folate supplement in various dosages. Strong evidence links folic acid 
supplementation to a decreased incidence of neural tube defects, and all authorities recommend an increased 
allowance for women of childbearing age. A Cochrane review summarized data from randomized and quasi-
randomized trials of daily periconceptional folic acid supplementation at doses of 360 µg to 4000 µg (0.36 mg-4 
mg)8. Folic acid supplementation may also be beneficial for preventing other congenital anomalies such as cleft 
lip/palate and heart defects; however, evidence from randomized trials is lacking. 
Iron 
Adequate elemental iron intake is important during pregnancy to maintain the increase in red blood cell mass and 
meet the oxygen requirements of the uteroplacental circulation9. Maternal anemia has been associated with 
LBW, preterm delivery, perinatal mortality, and maternal depression. A Cochrane review of 49 trials involving 
more than 20,000 pregnant women showed that although prophylactic iron supplementation was associated with 
higher hemoglobin levels in the peripartum period, there were no differences in maternal or neonatal clinical 
outcomes10. In addition, significant adverse effects were noted, especially hemoconcentration and constipation. 
This review was limited by significant heterogeneity in the study populations because the authors included trials 
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from a variety of countries in different phases of economic development. A recent study found an association 
between iron supplementation and gestational diabetes11. The RDA for iron during pregnancy is 27 mg/day.12. In 
the setting of iron deficiency anemia, supplementation of 60 mg/day to 80 mg/day of elemental iron is 
suggested9. The lowest necessary dose should be used. Vitamin C increases the absorption of iron. 
Multivitamin 
In the developing world, where the risk of malnutrition is high, multiple trials have been performed to assess the 
effects of prenatal multi micronutrient supplementation. Two recent systematic reviews and meta-analyses have 
demonstrated a decreased risk of SGA13, and LBW14 infants in women who received multi micronutrient 
supplements versus those who received standard iron-folic acid supplementation. Reductions in miscarriage, 
preterm birth, and stillbirth have not been consistently noted, and vitamins have been associated with an 
increased incidence of multiple gestation15. 
Most of the literature on multivitamin use in the developed world consists of observational studies, and many 
have found improved outcomes. Multivitamin use has been associated with a decreased risk of SGA infants16, 
specifically in non overweight women17, black women18, and low-income urban women19. The literature 
regarding preterm birth is conflicting, with some studies showing a decreased risk17,19,20, some showing no 
effect18, and 1 study showing an increased risk of preterm birth with multivitamin use20. A decreased risk of 
placental abruption has also been noted21, as well as a decreased risk of preeclampsia22. 
7.2 Category of drugs in pregnancy 
In 1979, the United States Food and Drug Administration (FDA) introduced a classification of fetal risks due to 
pharmaceuticals. The pregnancy category of a pharmaceutical agent is an assessment of the risk of fetal injury 
due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks 
conferred by pharmaceutical agents or their metabolites in breast milk23. 
The Food and Drug Administration (FDA) has developed a rating system to provide therapeutic guidance based 
on potential benefits and fetal risks. Drugs have been classified into categories A, B, C, D and X based on this 
system of classification. Drugs, and some multivitamins, that have demonstrated no fetal risks after controlled 
studies in humans are classified as Category A, while drugs like thalidomide with proven fetal risks that 
outweigh all benefits are classified as Category X. 
 
Pregnancy category 
A No risk in controlled human studies: Adequate and well-controlled human studies have failed to 
demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later 
trimesters). 
 
B No risk in other studies: Animal reproduction studies have failed to demonstrate a risk to the fetus and there 
are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse 
effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus 
in any trimester. 
 
C Risk not ruled out: Animal reproduction studies have shown an adverse effect on the fetus and there are no 
adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant 
women despite potential risks. 
 
D Positive evidence of risk: There is positive evidence of human fetal risk based on adverse reaction data from 
investigational or marketing experience or studies in humans, but potential benefits may warrant use of the drug 
in pregnant women despite potential risks. 
 
X Contraindicated in Pregnancy: Studies in animals or humans have demonstrated fetal abnormalities and/or 
there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing 
experience, and the risks involved in use of the drug in pregnant women clearly outweigh potential benefits. 
 
N FDA has not yet classified the drug into a specified pregnancy category24.      
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7.3 Empirical literature 
In a study, Festus, Emem, & John25 suggest that the practice of self-medication is common among pregnant 
women in our environment. In this study, various substances ranging from traditional preparations/substances 
including kola nuts and local gin to orthodox medications were found to have been used by the pregnant women. 
This study shows variation in the practice and use of self medication among the participants. In this study, about 
25% and 35% of the pregnant women with high level of education used analgesics and antibiotics respectively. 
This, when compared with 6.9% and 12.0% of them with low level of education involved in the use of the same 
substances, is very significant. Also about 6.9% of women with low education self-medicate herbs compared to 
5.6% of those with high education. These findings seem to suggest that the level of education influences the type 
and nature of substances used. It was also clear in the study that no pregnant woman smoked cigarette/tobacco or 
used any other potent substances, such Indian hemp cocaine or heroin. Several reasons may have contributed to 
this. First, these substances except tobacco, cigarette and Indian Hemp to a large extent are foreign to the 
environment and the knowledge of their usefulness, if any is limited. Although it is important to emphasize that 
the non use of these substances does not mean that they are not available. Secondly, the cost of obtaining them 
may be very high and affordability may also influence their usage. Finally, the custom, which restricts women 
from using certain substances, even in times of ill-health, may have also contributed to their non use. 
Also in another study, various orthodox medical regimens were found to be used by pregnant women. A 
significant proportion, 42% of pregnant women self-medicate analgesics, 37% antibiotics and 4% various forms 
of sedatives. Even though, these are modern medicine, the act of self-medication could be dangerous, 
considering the possible poor knowledge of pharmacodynamics of these medicines26. Antibiotics, such as 
septrin, chloramphenicol and tetracycline are dangerous and contraindicated during pregnancy27. Apart from the 
resistance that may result from inadequate dosing, exposing foetus to them in early months of pregnancy may 
result in various complications, such as, kernicterus, gray baby syndrome and respiratory distress. Non steroid 
anti inflammatory drugs for example widely used in pregnancy to treat fever pain and inflammation may cause 
embryo-foetal and neonatal adverse effect. Example to NSAIDs in early pregnancy is associated with increased 
risks of miscarriage and malformations and after 30 weeks of gestations is related with an increased risk of 
premature closure f foetal ductus artereosus and oligo hydromnios28. Other drugs used by pregnant women 
during prenatal period like immune suppressant drugs are not associated with higher risk of congenital 
abnormalities but can be associated with an increased incidence of prematurity, intra uterine growth retardation 
and low birth weight29.   
In a population based survey cohort study in Sweden30, found that 57.6% purchased at least one prescribed drug 
during pregnancy and 50.9% during lactating period. The most widely purchased drug during pregnancy were 
antibacterial for systematic used, followed by sex hormone, NSAIDs, antidepressant and drugs for the 
respiratory system. Antibiotic were the most dispensed prescribed drugs during pregnancy. The most prescribed 
antibiotic were B-lactam antibacterial and penicillin and there were strong decline in the dispensed antibiotic not 
recommended in pregnancy. This is more worrisome as the sources and instructions concerning the use of these 
medicines are not from professionals. One major concern would be issue of inadequate dosing and resistance 
with respect to antibiotics. The widespread use of suboptimal dosages of antibiotics is a major threat, 
contributing to the development of resistant bacterial strains31. 
8. Study design and Method 
The study was retrospective descriptive cross sectional survey that assessed the drugs use among pregnant 
women in Sir Yahaya Memorial Hospital Birnin Kebbi. 
8.1 Population of the study 
The Target population comprised of all the pregnant women attending ANC in Sir Yahaya Memorial Hospital 
Birnin Kebbi. 
8.2 Sampling method 
Systematic sampling was used in selecting sample of the research using sampling frame collected from the 
hospitals’ ANC unit.  
8.3 Sample size determination 
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The sample size was calculated using the Cochran’s equation for sample proportion, at 95% confidence, 5% 
level of precision, and the estimate proportion of an attribute present in the population of the study is assumed to 
be 50%. 
  t2pq 
                         no=      
    d2 
t= selected alpha level in each tail 
(p)(q)= estimate of variance. Maximum possible proportion is 0.5 
1- Maximum possible proportion produces maximum possible sample size.  
d= acceptable margin of error for proportion being estimated = 0.0532. 
t = 1.96                                          1.962 × 0.5 × 0.5                      =   384 
p = 0.5                    =                              0.0025                                   
d = 0.05 
The sample size of 384 exceed 5%, the Cochran’s correction formulae was used to calculate final sample size32. 
n1= no/1+no/N                                                      where N = population 
         n1 = final sample size 
n1 =       384/1+384/671 = 244 
Therefore the sample size was 244         
 
8.4 Method of data collection 
Data was collected using 25 items structured questionnaire administered to the respondents during their clinic 
session. A respondent that could not read English was interviewed using the questionnaire. Thus research 
assistance was trained for the purpose of administering and interviewing the respondents. 
8.5 Validity and reliability 
Face and content validity was used to validate the research instrument by giving the instrument to at least three 
experienced people in the research subject. Test-retest reliability was used to ascertain the reliability of the 
questionnaire and found to have the reliability of 8.4 
8.6 Ethical consideration 
Permission was obtained from the hospital management, and ethical approval was collected from Kebbi State 
Health Research Ethical Committee. The subjects of the study were made to involve in the research voluntarily, 
and information provided was treated as confidential.  
8.7 Method of data analysis 
Data was analysed using descriptive statistic in tables indicating percentages and frequencies; and Chi square 
statistical tool in hypotheses testing using SPSS version 20.  
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9. Result 
Table 1: Socio-demographic data of the respondents 
Variables 
15-24 
25-34 
35-44 
≥ 45 
Number of deliveries 
0-3 
4-6 
7-9 
≥10 
Educational level 
Primary education 
Secondary education 
Tertiary education 
Non-formal education 
Non response 
Occupation 
Civil servant 
Business 
Hand work 
House wife 
 
Frequencies  
107 
96 
38 
3 
 
42 
102 
72 
28 
 
42 
95 
34 
72 
1 
 
22 
37 
38 
147 
Percentages 
43.9 
39.3 
15.6 
1.2 
 
17.2 
41.8 
49.5 
11.5 
 
17.2 
38.9 
13.9 
29.5 
0.4 
 
9.0 
15.2 
15.6 
60.2 
Table 1 above shows that most of the respondents (43.9%) were within the age of 15-24 year, and only 1.2% 
were found to be ≥ 45 year. 49.5% of the respondents delivered 7-9 times and only 13.9% attended tertiary 
education. Majority of the respondents (60.2%) were living only as house wives. 
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 Table 2: Questions pertaining prescribed and non-prescribed drugs 
Questions Frequency Percentage 
Do you attend ANC clinic regularly? 
 
Yes No Yes No 
214 30 87.7 
 
12.3 
 
Do you take the entire drugs prescribed to you at ANC 
clinic? 
123 121 50.4 
 
49.6 
 
Among the drugs prescribed to you at ANC clinic, is there 
any one you don’t like? 
160 
 
84 
 
65.6 
 
34.4 
 
Do you think all the drugs prescribed to you at ANC are 
important to you and your baby? 
196 
 
48 
 
80.3 
 
 
19.7 
 
 
Is there any drug prescribed to you at ANC that you think 
is detrimental to you or your baby? 
63 
 
181 
 
25.8 
 
 
74.2 
 
 
Is there any time the non-prescribed drug gives you 
problem? 
55 
 
189 
 
22.5 
 
 
77.5 
 
 
         Table 2 above indicates that 49.6% of the respondents were not taking the entire drugs prescribed to them, 
65.6% did not like some drugs prescribed to them at ANC clinic. 80.3% of the respondents believed that 
all the drugs prescribed to them at ANC clinic were important. However 25.8% of the respondents 
thought that some of the drugs prescribed to them at ANC clinic are detrimental to them or their babies; 
and 22.5% had problems due to non-prescribed drugs used.   
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        Table 3: Other questions pertaining prescribed and non-prescribed drugs 
Question Variable Percentage 
Which of the prescribed drugs do you 
dislike? 
 
Multivitamins 
Fersolate 
Folic acid 
Calcium gluconate 
Vitamin C 
Metronidazole 
Sulfadoxine plus 
pyrimethamine 
20.7 
20.0 
21.3 
9.6 
2.7 
3.9 
2.2 
Which of the prescribe drugs do you 
think is not important? 
 
 
 
 
Multivitamins 
Fersolate 
Folic acid 
Calcium gluconate 
Vitamin C 
Metronidazole 
9.5 
8.1 
9.4 
6.1 
3.6 
1.2 
What are the common non- prescribed 
drugs you used? 
Paracetamol 
Promethasine 
Ibuprofen 
Metronidazole 
Ampiclox 
Ciprofloxacin 
Chlorampenicol 
Artemether 
Magnesium trisilicate 
Cimitidine 
Omeprazole 
Amoxicillin 
Tetracycline 
Chloroquine 
Metronidazole 
 
72.3 
8.1 
11.5 
6.6 
6.6 
7.0 
5.6 
14.6 
8.3 
3.0 
3.1 
2.6 
8.4 
3.4 
1.2 
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Table 3 above indicates that 20.7% of the respondents dislike multivitamins among the prescribed 
drugs, 21.3% dislike folic acid and 20.0% dislike fersolate. 9.5% of the respondents think multivitamin 
is not important. 8.1%, 9.4% and 6.1% of the respondents think fersolate, folic acid and calcium 
gluconate respectively are not important. Majority of the respondents (72.3%) use paracetamol as non-
prescribed drugs, 11.5% use ibuprofen, 14.6% use artemether and 8.4% use tetracycline as non-
prescribed drugs.  
          Table 4: For how long do you take the drugs prescribed to you at ANC clinic? 
Variable Frequency Percentage 
5 days 59 24.2 
7 days 41 16.8 
10 days 22 9.0 
Several days 117 48.0 
Non response 5 2.0 
Total 244 100 
 Table 4 above revealed that 48.0% of the respondents take prescribed drugs for several days     and only 
16.8% take the drugs for 7 days. 
         Table 5: What do you do with the drugs you dislike? 
Variable Frequency Percentage 
Stop taking the drug 59 24.2 
Take it occasionally 85 34.8 
Take it by all means 69 28.3 
Change the drug 7 2.9 
Non response 24 9.8 
Total 244 100 
Table 5 indicates that 34.8% of the respondents take the drugs they dislike occasionally and 24.2% stop 
taking the drugs; however only 2.9% changed the drugs.   
Table 6: What do you do when you are sick in pregnancy? 
Variable Frequency Percentage 
Come to the hospital 163 66.8 
Buy drugs from medicine shop 56 23.0 
Use previous prescription 10 4.1 
Call health personnel at home 7 2.9 
Non response  8 3.3 
Total 244 100 
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Table 6 above shows that 66.8% of the respondents come to the hospital when they are sick, 23.0% buy 
drugs from medicine shop and only 4.1% use previous prescription when they are sick. 
         Table 7: In what months of pregnancy do you mostly take non-prescribed drugs? 
Variable Frequency Percentage 
1-3 months 73 29.9 
4-6 months 65 26.6 
7-9 months 20 8.2 
All months 46 18.9 
Non response 40 16.4 
Total 244 100 
Table 7 above shows that 29.9% of the respondents take non-prescribe drugs in fisrt trimester of 
pregnancy and 8.2% in third trimester.  
Table 8: For how long do you take the non-prescribed drug? 
Variable Frequency Percentage 
5 days 90 36.9 
7 days 30 12.3 
10 days 4 1.6 
Several days 70 28.7 
Non response 50 20.5 
Total 244 100 
Table 8 above indicates that 36.9% of the respondents take non-prescribed drugs for five days, 28.7% 
for several days and 12.3% for 7 days. 
10. Discussion of findings  
The result shows that majority of the respondents (43. 9%) were within the age bracket of 15-24 years, also 
49.5% of the respondents delivered 7-9 times. The relationship between the two findings may be an indication of 
poor family planning practice among the respondents. It is also in congruence with respondents’ level of 
education in which only 13.9% attended tertiary institution (Table 1). Thus lack of high level of education could 
leads to early marriages and decline from family planning practice. In table 2 it is shown that there is problem 
with the use of ANC drugs, this is clear as 49.6% of the respondents were not taking the entire drugs prescribed 
to them. However 80.3% of the respondents believed that all the drugs prescribed to them at ANC clinic are 
important. One element that shows lack of knowledge on drugs prescribed at ANC is that 25.8% of the 
respondents believed that some drugs prescribed at ANC clinic are detrimental to them or their foetuses.  
The alarming findings of the result are that 20.7%, 21.3% and 20.0% of the respondents dislike multivamins, 
folic acid and fersolate respectively among the ANC prescribed drugs. 9.5% of the respondents think 
multivitamin is not important. 8.1%, 9.4% and 6.1% of the respondents think fersolate, folic acid and calcium 
gluconate respectively are not important (This is found in table 3). They are vitamins and minerals supplement 
that help in the prevention of pregnancy and delivery associated complications. Conditions such as anaemia, 
haemorrhages and congenital abnormalities are prevented using vitamins and minerals supplements. Moreover 
34.8% of the respondents take the drugs they dislike occasionally and 24.2% stop taking the drugs; however 
28.3% take the drugs by all means (Table 5).   
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When asked on the use of non-prescribed drugs, 72.3% of the respondents used paracetamol, 11.5% ibuprofen, 
14.6%artemether and 8.4% tetracycline. Ibuprofen, artemether and tetracycline are best to be avoided in 
pregnancy. When asked for how long the respondents take their prescribed drugs, Table 4 indicates that 48.0% 
take the drugs for several days and only 16.8% take the drugs for 7 days. Several days here means more than 10 
days and the drugs taken for several days might include those need not be taken for long time, and some may be 
harmful to the mother or foetus when taken for such period of time.  
Table 6 shows that majority of the respondents (66.8%) go to the hospital when they are sick, 23.0% buy drugs 
from medicine shop and only 4.1% use previous prescription when they are sick. Thus most of the respondents 
are having positive attitude of attending hospital when sick. However the percentage of the respondents (23.0%) 
that buy drugs from the medicine shop could be considered significant enough to be taken as threat, looking at 
the potential risk associated with self medication in pregnancy. When asked in what months of pregnancy they 
mostly take non-prescribed drugs, table 7 shows that 29.9% of the respondents take non-prescribed drugs in first 
trimester of pregnancy, the most delicate of the pregnancy periods, and 8.2% in third trimester. This indicates 
that some of the respondents expose themselves and their foetuses to the risk of teratogenic effects of the drugs. 
More over 28.7% of the respondents when asked revealed that they take non-prescribed drugs for several days 
(Table 8); which may reinforce the likely hood of teratogenic effect and other adverse effects on the mother 
including pregnancy and delivery complications. 
In the hypotheses testing the results show that at 0.05 level of significant age has no effect on the use of 
prescribed drugs, P is 0.35 (P>0.05); age has effect on what the pregnant women do with the drugs they dislike, 
P is 0.04 (P<0.05) and age has effect on the common non-prescribed drugs pregnant women used, P is 0.03 
(P<0.05). 
At 0.05 level of significant, level of education has no effect on the use of prescribed drugs, P is 0.76 (P>0.05); 
level of education has no effect on what the pregnant women do with the drugs they dislike, P is 0.65 (P>0.05) 
and level of education has effect on common non-prescribed drugs pregnant women used, P is 0.00 (P<0.05). 
At 0.05 level of significant number of deliveries has effect on the use of prescribed drugs, P is 0.01(P<0.05); 
number of deliveries has no effect on what the pregnant women do with the drugs they dislike, P is 0.89 
(P>0.05) and number of deliveries has no effect on non-common prescribed drugs pregnant women used, P is 
0.84 (P>0.05). 
11. Conclusion 
The assessment of drugs use among pregnant women in Sir Yahaya Memorial Hospital Birnin-Kebbi comes with 
so many different findings including the ways by which the pregnant women used prescribed and non-prescribed 
drugs. It shows that there were some problems that need to be addressed. Lacks of knowledge, beliefs and wrong 
perception on the use of drugs have a tremendous influence on the way pregnant women use drugs. The result 
shows a serious misconception that could leads to a devastating effect on the mother and foetus health especially 
misconception on the use of multivitamins, minerals and iron that some respondents considered as not important; 
Thus about half of the respondents do not take the entire drugs prescribed to them. Moreover some of the 
respondents used drugs contraindicated in pregnancy and about half of the respondents take drugs for more than 
prescribed days which might leads to some teratogenic effects. Self medication is low among the respondents, 
but self medication in pregnancy to whatever extent needs to be addressed; as it effect on the mother and foetus 
could not be that mild. There exist more risks of teratogenicity as considerable number of respondents said to 
take non-prescribed drugs in first trimester of pregnancy. 
12. Recommendations  
1. More effort should be applied in educating pregnant women on all aspect of drugs use in pregnancy especially 
during ANC visit. 
2. Importance of multivitamins, minerals and iron supplement in pregnancy should be stressed.   
3. Pregnant women should be educated on taking the drugs for the prescribed days and disadvantages of not 
doing so.  
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